Maryse Mestre-Lapeyre

Toulouse, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 293 publications

Opioid agonist treatment and risk of mortality in French primary care: a nationwide, retrospective cohort study.

Opioid agonist treatment and risk of mortality in French primary care: a nationwide, retrospective cohort study.

Journal: The Lancet. Public health

Published: January 06, 2026

Pharmacovigilance in the field of addiction: challenges and emerging solutions.

Pharmacovigilance in the field of addiction: challenges and emerging solutions.

Journal: Expert review of clinical pharmacology

Published: December 04, 2025

Impact of parameter settings on the estimation of drug exposure with the individualized dispensing patterns method.

Impact of parameter settings on the estimation of drug exposure with the individualized dispensing patterns method.

Journal: British journal of clinical pharmacology

Published: November 20, 2025

No increased risk of acute myeloid leukemia in adults with primary immune thrombocytopenia treated with thrombopoietin receptor agonists: a French nationwide population-based study.

No increased risk of acute myeloid leukemia in adults with primary immune thrombocytopenia treated with thrombopoietin receptor agonists: a French nationwide population-based study.

Journal: Haematologica

Published: November 10, 2025

Risk of thrombosis in adults with primary immune thrombocytopenia treated with eltrombopag vs romiplostim: a target trial emulation in the French Adult Immune Thrombocytopenia (FAITH) cohort.

Risk of thrombosis in adults with primary immune thrombocytopenia treated with eltrombopag vs romiplostim: a target trial emulation in the French Adult Immune Thrombocytopenia (FAITH) cohort.

Journal: Journal of thrombosis and haemostasis : JTH

Published: October 22, 2025

Cannabis and Cannabinoid-Related Suspected Adverse Drug Reactions: Global Patterns and Cross-National Analysis Based on VigiBase® Data.

Cannabis and Cannabinoid-Related Suspected Adverse Drug Reactions: Global Patterns and Cross-National Analysis Based on VigiBase® Data.

Journal: CNS drugs

Published: October 16, 2025

Socioeconomic deprivation, disease complications and access to preventive care in sickle cell disease in mainland France.

Socioeconomic deprivation, disease complications and access to preventive care in sickle cell disease in mainland France.

Journal: Annals of hematology

Published: October 02, 2025

Real-World Effectiveness and Safety of Fostamatinib in Difficult-to-Treat Immune Thrombocytopenia Patients. A Prospective, Multicenter Registry in France.

Real-World Effectiveness and Safety of Fostamatinib in Difficult-to-Treat Immune Thrombocytopenia Patients. A Prospective, Multicenter Registry in France.

Journal: American journal of hematology

Published: September 18, 2025

Impact of regulatory changes on the use of baclofen in alcohol use disorders between 2014 and 2021, using the French National Health Data System.

Impact of regulatory changes on the use of baclofen in alcohol use disorders between 2014 and 2021, using the French National Health Data System.

Journal: Scientific reports

Published: August 13, 2025

Impact of urine drug screening on opioid agonist treatment maintenance with buprenorphine in primary care in France: A cluster-randomized trial.

Impact of urine drug screening on opioid agonist treatment maintenance with buprenorphine in primary care in France: A cluster-randomized trial.

Journal: Therapie

Published: May 09, 2025

Characteristics of Drug-RElated Hospitalizations for Nursing HOme Residents: Cross-Sectional RENHO Study.

Characteristics of Drug-RElated Hospitalizations for Nursing HOme Residents: Cross-Sectional RENHO Study.

Journal: Drug safety

Published: May 05, 2025

Response to "Before a diagnosis of secondary catatonia due to chronic nitrous oxide use is made, all alternative causes must be ruled out".

Response to "Before a diagnosis of secondary catatonia due to chronic nitrous oxide use is made, all alternative causes must be ruled out".

Journal: Drug and alcohol review

Published: April 04, 2025

Showing 1-12 of 293

Last Updated: 09/26/2026